StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
HYGN.JK$142.00+4.41%
Fair $142.00+0.0%

HYGN.JK

HYGN.JK

Industrials / Specialty Business ServicesJakartaID

$142.00

+6.00 (+4.41%)

Fairly Valued+0.0%Fair Value $142.00Fund rank 29/100 · Data gapFallback financials|
SA 35/D
F-Score: 8/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 22%

FCF escenarios

weak_data · normalized FCF $-8.7B · quality 50.7/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 22/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

35/100

D

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: eodhdPeriods: 6Warnings: 0eodhd: 6
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · HYGN.JKLocal privado en este navegador · HYGN.JK
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$354.7B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

11.6%

↑

Gross Margin

36.0%

↑

Debt/Equity

0.02

↓
52-Week Range$142
$122$197

TradingView lightweight chart

HYGN.JK price, volumen y niveles de valoración

Último $142.00Periodo -13.9%
Fair value: $142.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2020–2025 · 5 años de histórico normalizado

Revenue CAGR

+20.1%

FCF CAGR

+0.8%

FCF margin

5.1%

FCF / Net income

0.94x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $360.59B · net income $19.71B · FCF $18.53B

2020-FY → 2025-FY

Gross margin

36.0%-8.2% pts

Operating margin

6.3%-4.0% pts

Net margin

5.5%-2.1% pts

FCF margin

5.1%-7.2% pts
MetricTTM
2025
2024
2023
2022
2021
2020
Income Statement
Revenue$360.59B$360.59B$309.34B$235.64B$186.46B$156.03B$144.17B
Net Income$19.71B$19.71B$18.64B$18.17B$15.12B$10.10B$10.92B
EBITDA——$42.06B$31.06B$32.51B$28.48B$29.78B
EPS7.857.857.519.097.565.055.46
Gross Margin36.0%36.0%37.9%41.8%44.8%45.4%44.1%
Operating Margin6.3%6.3%8.0%7.5%9.1%8.2%10.3%
Net Margin5.5%5.5%6.0%7.7%8.1%6.5%7.6%
Balance Sheet
Debt/Equity0.020.020.100.350.190.200.15
Current Ratio3.993.992.581.411.471.321.06
Cash Flow
Free Cash Flow$18.53B$18.53B$-17.44B$-8.73B$9.91B$16.83B$17.82B
Returns
ROE11.6%11.6%11.8%24.4%21.9%18.8%25.2%
Growth & Yield
Revenue Growth16.6%16.6%31.3%26.4%19.5%8.2%—
EPS Growth4.6%4.6%-17.3%20.2%49.8%-7.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

17.1%

exigente

EPS terminal req.

$12.60

Spread vs growth

-12.5%

5Y implied EPS CAGR

14.2%

razonable

EPS terminal req.

$15.25

Spread vs growth

-9.6%

10Y implied EPS CAGR

12.1%

razonable

EPS terminal req.

$24.55

Spread vs growth

-7.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +0.0%

Total return

+0.0%

Start / end P/E

18.9x → 18.1x

EPS bridge

7.51 → 7.85

Residual

-0.2%

EPS growth+4.6%
Multiple rerating-4.4%
Dividend+0.0%
Residual / FX / buybacks / cross-term-0.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.